Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
26 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

PRNAD — ALTERITY THERAPEUTICS LTD Dilution Risk Tracker

Track PRNAD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PRNAD — Get alerts when the score changes →

As of October 13, 2026, ALTERITY THERAPEUTICS LTD (PRNAD) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. ALTERITY THERAPEUTICS LTD has 217.51M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊Float Risk—
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for PRNAD.
🔔 Track PRNAD — Get forecast alerts →

Market Data

Market CapN/A
Shares Outstanding217.51M
FloatN/A
CashN/A
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore26/100DilutionWatch score record
Shares Outstanding217.51MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market CapNot availableMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

Institutional data not yet available.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

PRNAD's DilutionScore is currently 26/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 21/100 (Low risk).

Period Score Risk Level Duration
Sep 04 – Oct 13, 202626/100MEDIUM40 days
Aug 22 – Sep 03, 202621/100LOW13 days
Jul 22 – Aug 21, 202618/100LOW30 days
Jul 16 – Jul 21, 202612/100LOW6 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track PRNAD Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PRNAD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PRNAD — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT AATC ACMR ADTTF AEMRF AGGID AHRT AI AIJTY ALDX

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note